Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Injection medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor

A technology of glucocorticoids and compositions, applied in the field of injection pharmaceutical compositions, which can solve the problems of ambiguous pharmacological effects and large side effects, and achieve the effect of improving anti-inflammatory effects

Active Publication Date: 2013-03-06
TIANJIN JINYAO GRP
View PDF10 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its reduction of NO synthesis may be the main mechanism of side effects such as vascular endothelial dysfunction and pain sensitization. At the same time, it has also been reported that combining non-steroidal anti-inflammatory drugs of foreign companies with nitric oxide can have better analgesic and anti-inflammatory effects ( CN200880004081.5), so there is still a big difference in which of nitric oxide and nitric oxide synthase inhibitors can play a better anti-inflammatory effect in the body. Due to the ambiguous pharmacological effects and relatively large side effects, NOS Inhibitors are not currently administered as drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Injection medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor
  • Injection medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor
  • Injection medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Embodiment 1, the preparation of glucocorticoid cyclodextrin increasing solution

[0021] Example number

[0022] Dissolve 6g of cyclodextrin in 100ml of 95% ethanol at room temperature, add 1g of glucocorticoid under nitrogen protection, stir to dissolve, stir for another 30 minutes, filter, add 50ml of water for injection, stir for 5 minutes, concentrate under reduced pressure, evaporate Remove ethanol to obtain glucocorticoid / cyclodextrin solution for later use.

Embodiment 2

[0023] Embodiment 2, the preparation of NOS inhibitor cyclodextrin solubilization solution, the obtained cyclodextrin solubilization solution

[0024] Example number

[0025] Dissolve 5 g of cyclodextrin in 100 ml of 95% ethanol at room temperature, add 1 g of NOS inhibitor under nitrogen protection, stir, stir for another 30 minutes, filter, add 50 ml of water for injection, stir for 5 minutes, concentrate under reduced pressure, evaporate ethanol, The NOS inhibitor / cyclodextrin liquid was obtained and kept under nitrogen protection for later use.

Embodiment 1

[0026]Formulation Example 1 (injection containing cyclodextrin)

[0027] Active ingredient:

[0028] Hydrocortisone Cyclodextrin Solubilization Solution (1-5) Equivalent to Hydrocortisone 10.0g

[0029] Aminoguanidine hydrochloride cyclodextrin solubilization solution (2-7) equivalent to aminoguanidine 1g

[0030] Accessories:

[0031]

[0032] Take the prescribed amount of hydrocortisone cyclodextrin solubilization solution, aminoguanidine hydrochloride cyclodextrin solubilization solution, propylene glycol, sodium pyrosulfite, and sodium chloride and dissolve them in part of the water for injection, and use disodium hydrogen phosphate, dihydrogen phosphate Adjust the pH of the sodium buffer solution to 6.8, add water for injection to 1000ml, sterilize, and pack aseptically. Obtaining injection dosage is hydrocortisone 10mg / ml, aminoguanidine 1mg / ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an injection medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor, containing glucocorticoid which is used as an active ingredient, NOS inhibitor, and one or more pharmaceutical excipients suitable for injection.

Description

technical field [0001] The invention relates to a pharmaceutical composition, an injection pharmaceutical composition containing corticosteroids and NOS inhibitors. Background technique [0002] Glucocorticoids have anti-inflammatory, anti-allergic, anti-rheumatic, and immunosuppressive effects, and are widely used in the treatment of allergic and autoimmune inflammatory diseases. Such as connective tissue disease, active rheumatism, rheumatoid arthritis, lupus erythematosus, severe bronchial asthma, severe dermatitis, ulcerative colitis, acute leukemia, etc. It is also used for some serious infections, poisoning, and malignant lymphoma. treat. Although glucocorticoids are widely used, they are likely to cause many side effects when used for a long time or in large doses, such as Cushing's syndrome, osteoporosis, aseptic femoral head necrosis, and the induction and aggravation of infection. [0003] NO is an inorganic small molecule with a wide range of biological function...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/573A61K31/58A61K31/56A61K31/57A61K31/198A61K31/155A61P29/00A61P19/02A61P19/04A61P37/02
Inventor 孙亮陈松赵琳
Owner TIANJIN JINYAO GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com